2025; 3:102303.
. P338: Studying the role of the DIP2C gene in humans and zebrafish. Genetics in Medicine Open.Genomic sequencing in diverse and underserved pediatric populations: Parent perspectives on understanding, uncertainty, psychosocial impact, and personal utility of results. Genetics in Medicine. 2025; 27:101363.
.Statistical signature of subtle behavioral changes in large-scale assays. Editor, Marinazzo D. PLoS Computational Biology. 2025; 21:e1012990.
.Decision stability among adolescents and young adults making choices about learning genomic research results. Journal of Genetic Counseling. 2025; 34:e2010.
.Cellular Communication Network Protein 2 in the Right Ventricle of Pulmonary Arterial Hypertension. Pulmonary Circulation. 2025; 15:e70067.
.2025; 3:102154.
. P189: Endocrinopathies in TAOK1-related neurodevelopmental disorders: An expanded case series on the evolution of symptoms in adolescents and young adults. Genetics in Medicine Open.Race-Specific and Race-Neutral Equations for Lung Function and Asthma Diagnosis in Black Children. JAMA Network Open. 2025; 8:e2462176.
.Correspondence on "Weighty matters: Considering the ethics of genetic risk scores for obesity " by C. Houtz. Genetics in Medicine. 2025; 27:101324.
.Newborn screening follow-up for very long-chain acyl-CoA dehydrogenase deficiency in Colorado: Working towards a standardized protocol. Molecular Genetics and Metabolism. 2025; 145:109104.
.Dual Diagnosis of Fragile X Syndrome and DEPDC5-Related Disorder Emphasizes DEPDC5's Role Beyond Familial Epilepsy: A Case Report and Literature Review. Editor, Das SP. Case Reports in Genetics. 2025; 2025:4501466.
.Case Report: A novel missense variant in ZC4H2, c.196C>T p.(Leu66Phe), is associated with a mild, ZC4H2-related X-linked syndromic intellectual disability (ZARD) phenotype. Frontiers in Pediatrics. 2025; 13:1518782.
.A novel POT1-TPD presentation: A germline pathogenic POT1 variant discovered in a patient with newly diagnosed posterior fossa ependymoma. Cancer genetics. 2025; 292-293:38-43.
.Adolescents' and young adults' reactions to and perceived utility of carrier screening results in the context of a genomic research study. Journal of Genetic Counseling. 2025; 34:e70027.
.Lysosomal dysfunction and inflammatory sterol metabolism in pulmonary arterial hypertension. Science. 2025; 387:eadn7277.
.Tet Methylcytosine Dioxygenase 2 (TET2) Mutation Drives a Global Hypermethylation Signature in Patients With Pulmonary Arterial Hypertension (PAH): Correlation With Altered Gene Expression Relevant to a Common T Cell Phenotype. Comprehensive Physiology. 2025; 15:e70011.
.2025; 144:108766.
. Miglustat: A first-in-class enzyme stabilizer for late-onset Pompe disease. Molecular Genetics and Metabolism.2025; 144:108768.
. Evaluating the relationship between infusion-related reactions and anti-drug antibody status: Results from 111 patients with Fabry disease treated with pegunigalsidase alfa. Molecular Genetics and Metabolism.2025; 4:2383163.
. Plain Language Summary: Looking at treatment outcomes in people with Fabry disease who started agalsidase beta before the age of 30 years. Future Rare Diseases.2025; 144:108769.
. Quality of life of migalastat-treated adolescents with Fabry disease: Results from the ASPIRE study and open-label extension. Molecular Genetics and Metabolism.2025; 144:108773.
. Isaralgagene civaparvovec (ST-920) gene therapy in adults with Fabry disease: Updated results from an ongoing phase 1/2 study (STAAR). Molecular Genetics and Metabolism.Update on Retinoblastoma Predisposition and Surveillance Recommendations for Children. Clinical Cancer Research. 2025; 31:1573-1579.
.Mosaic X-linked adrenoleukodystrophy in males identified by newborn screening and next-generation sequencing. npj Genomic Medicine. 2025; 10:38.
.Ring Chromosome 17 Syndrome-A Case Report and Discussion of Diagnostic Methods. American Journal of Medical Genetics, Part A. 2025; 197:e63925.
.2025; 144:108819.
. Improved growth in children with Fabry disease during treatment with agalsidase beta: A Fabry Registry analysis. Molecular Genetics and Metabolism.A zebrafish model of crim1 loss of function has small and misshapen lenses with dysregulated clic4 and fgf1b expression. Frontiers in Cell and Developmental Biology. 2025; 13:1522094.
.A Dual Diagnosis of Okur-Chung Neurodevelopmental Syndrome and Becker Muscular Dystrophy: Inquiry Into the Lower Limits of Neurodevelopmental Functioning Attributable to Muscular Dystrophy. Brain and Behavior. 2025; 15:e70276.
.2025; 144:108840.
. Lower rate of infusion-related reactions in patients with Fabry disease after switching from agalsidase beta to pegunigalsidase alfa. Molecular Genetics and Metabolism.Clinical, Immunologic, and Genetic Characteristics in Patients With Syndrome of Undifferentiated Recurrent Fevers. Arthritis and Rheumatology. 2025; 77:596-605.
.Update on Cancer Screening in Children with Syndromes of Bone Lesions, Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome, and Other Rare Syndromes. Clinical Cancer Research. 2025; 31:457-465.
.Social Environment and Neurobehavioral Outcomes 1 Year After Severe Pediatric TBI in the Intensive Care Unit. The Journal of Head Trauma Rehabilitation. 2025; 40:147-156.
.2025; 104.
. Miglustat: A First-In-Class Enzyme Stabilizer for Late-Onset Pompe Disease (P10-2.012). Neurology.2025; 34.
. Survey research in genetic counseling. Journal of Genetic Counseling.Cardiac genetic counseling services: Exploring downstream revenue in a pediatric medical center. Journal of Genetic Counseling. 2025; 34:e1984.
.The phenotypic spectrum of the Cornelia de Lange-like "Alazami-Yuan syndrome ": A case report of the 7th diagnosed individual and review of the literature. Clinical Case Reports. 2025; 13:e9208.
.BCL11A intellectual developmental disorder: defining the clinical spectrum and genotype-phenotype correlations. European Journal of Human Genetics. 2025; 33:312-324.
.Genetic counseling for the dystrophinopathies-Practice resource of the National Society of Genetic Counselors. Journal of Genetic Counseling. 2025; 34:e1892.
.Safety and efficacy of migalastat in adolescent patients with Fabry disease: Results from ASPIRE, a phase 3b, open-label, single-arm, 12-month clinical trial, and its open-label extension. Molecular Genetics and Metabolism. 2025; 145:109102.
.2025; 144:108910.
. Long-term safety and efficacy of migalastat in adolescent patients with Fabry disease: Results from the ASPIRE study and open-label extension. Molecular Genetics and Metabolism.Balancing independence: Priorities, tensions, obstacles, and facilitators for independence among young adults with skeletal dysplasia and short stature. Journal of Genetic Counseling. 2025; 34:e70033.
.High rates of placental inflammation among samples collected by the Multi-Omics for Mothers and Infants consortium. American Journal of Obstetrics and Gynecology. 2025; 232:230.e1-230.e19.
.Heterozygous UBR5 variants result in a neurodevelopmental syndrome with developmental delay, autism, and intellectual disability. The American Journal of Human Genetics. 2025; 112:75-86.
.Oral Infigratinib Therapy in Children with Achondroplasia. The New England Journal of Medicine. 2025; 392:865-874.
.2025; 3:102089.
. O13: Oral infigratinib for children with achondroplasia: Month 18 results from the PROPEL 2 study. Genetics in Medicine Open.Update on Pediatric Surveillance Recommendations for PTEN Hamartoma Tumor Syndrome, DICER1-Related Tumor Predisposition, and Tuberous Sclerosis Complex. Clinical Cancer Research. 2025; 31:234-244.
.2025; 3:e000900.
. Association between gestational weight gain and adverse pregnancy outcomes: cohort analysis from South Asia and Sub-Saharan Africa.Haplotype-based analysis distinguishes maternal-fetal genetic contribution to pregnancy-related outcomes. Editor, Cordell HJ. PLoS Genetics. 2025; 21:e1011575.
.Electronically Monitored Antidepressant Adherence in Adolescents with Anxiety Disorders: A Pilot Study. Journal of Child and Adolescent Psychopharmacology. 2025; 35:145-154.
.RORA-neurodevelopmental disorder: A unique triad of developmental disabilities, cerebellar anomalies, and myoclonic seizures. Genetics in Medicine. 2025; 27:101347.
.2025; 3:102227.
. P262: Transformative care through genome sequencing: Insights from the first 100 patients in the CincyKidsSeq Study. Genetics in Medicine Open.2025; 3:101955.
. 38: Adoption of the ACMG and ClinGen copy number variant (CNV) technical standards in clinical genetic laboratories in the United States. Genetics in Medicine Open.Editorial: Recent advances in causes, diagnosis, and therapeutics for congenital heart defects. Frontiers in Genetics. 2025; 16:1564492.
.Guidance for shared decision-making regarding orchiectomy in individuals with differences of sex development due to 17-β-hydroxysteroid dehydrogenase type 3 deficiency. Frontiers in Pediatrics. 2025; 13:1549400.
.A Case Study of a Female Infant With Primary Hypertrophic Osteoarthropathy Demonstrates That Early Initiation of Celecoxib Slows but Does Not Prevent Symptom Progression. American Journal of Medical Genetics, Part A. 2025; 197:e64000.
.